---
title: "MIR125A"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "## Information about gene MIR125A"
tags: ['MIR125A', 'MicroRNA', 'Cancer', 'GeneExpression', 'PotentialTherapy', 'SomaticMutations', 'TargetedTherapy', 'TumorSuppressor']
---

## Information about gene MIR125A

**Genetic Position:** Located on chromosome 19q13.41

**Pathology:** MIR125A has been found to be deregulated in various cancers, including hepatocellular carcinoma, gastric cancer, breast cancer, cervical cancer, and lung cancer.

**Function:** MIR125A is a microRNA that plays a role in regulating gene expression. It is involved in various cellular processes, including cell proliferation, differentiation, and apoptosis.

**External IDs:** 
- HGNC: HGNC:31512
- NCBI Entrez: 406956
- Ensembl: ENSG00000205594
- OMIM: 610765
- UniProtKB/Swiss-Prot: Not available

**Aliases:** MIRN125A, hsa-mir-125a-5p, MIRN125-1, MIRN125-2

**AA Mutation List:** There are currently no annotated amino acid mutations for MIR125A.

**Somatic SNVs/InDels:** Several somatic SNVs/InDels have been reported in MIR125A in various cancers, but no dbSNP IDs are available.

**Related Disease:** MIR125A is implicated in various cancers, including hepatocellular carcinoma, gastric cancer, breast cancer, cervical cancer, and lung cancer.

**Treatment and Prognosis:** The deregulation of MIR125A in cancer suggests that it may be a potential target for cancer therapy. However, more research is needed to determine its potential for clinical use.

**Drug Response:** There is currently no information available regarding the drug response of MIR125A.

**References:** 
- Liang D, Zhou Y, Huang J, Luo N, Zhang Y, Jin K, et al. MiRNA-125a-5p inhibits cell proliferation and induces apoptosis in HepG2 cells. Acta Biochim Biophys Sin (Shanghai) 2012;44(9):726-734. doi:10.1093/abbs/gms054
- Liu W, Yu Q, Liu Y, Huang X, Zhang X, Zhang L, et al. MiR-125a-5p functions as a tumour suppressor in breast cancer by downregulating STAT3. BMC Cancer 2019;19(1):759. doi:10.1186/s12885-019-5968-y
- Yang X, Zhang Z, Wang J, Li W, Xu J, Zhao F, et al. The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer. Neoplasma 2020;67(3):499-508. doi:10.4149/neo_2019_190108N11

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**